Evogene Capital Reinvestment Ratio

Latest as of December 2012: 2.78x

Evogene capital reinvestment ratio. Evogene (EVGN) has a Capital Reinvestment Ratio of 2.78x as of December 2012, meaning it reinvests 3% of its operating cash flow (ILA100.00K) in capital expenditures (ILA278.00K). Check Evogene investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

2.78x
Capex / Operating Cash Flow

Operating Cash Flow

ILA100.00K
ILA

Capital Expenditures

ILA278.00K
ILA

Data as of

Dec 2012
Most recent filing

Capital Reinvestment Ratio of Evogene (2008–2011)

Capital reinvestment ratio of Evogene from 2008 to 2011. This chart tracks Evogene's Capital Reinvestment Ratio across 3 annual periods. Also explore EVGN net asset momentum to track the company's year-over-year net asset growth rate.

Evogene Capital Reinvestment Ratio by Year (2008–2011)

Evogene capital reinvestment ratio by year from 2008 to 2011. For the full cash flow conversion analysis, see Evogene (EVGN) cash flow conversion.

Year Reinvestment Ratio Operating CF (ILA) Capital Expenditures YoY Change
2011 1.76x ILA2.13 Million ILA3.76 Million ▼ -39.6%
2009 2.92x ILA886.00K ILA2.59 Million ▲ +3934.4%
2008 0.07x ILA12.61 Million ILA912.00K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow